NAC for endometriosis: striking observational evidence, honest about its limits
NAC for endometriosis: a non-prescription antioxidant with the most striking observational evidence in this category
Time to effect
Dose
Active compound
▪ The challenge at hand
N-acetylcysteine (NAC) is a precursor to glutathione, the body's primary intracellular antioxidant, and endometriosis is associated with high oxidative stress in the peritoneal environment. A well-designed Italian cohort study offered women scheduled for laparoscopy either NAC or no treatment for three months before the procedure, and the finding was striking: endometrioma diameter stabilized or decreased in the NAC group while growing significantly in untreated controls.
The critical honest framing: this was an observational cohort study, not a randomized controlled trial. Women chose whether to take NAC, which introduces selection bias, and this is explicitly categorized as emerging evidence for this reason. The 2013 paper has since been supported by a 2023 prospective cohort study from the same group showing pain and CA-125 reductions. The evidence is consistent and the mechanism is plausible, but a well-powered RCT hasn't been done. For people with endometriosis seeking non-prescription options with a favorable safety profile, this is worth knowing about honestly.
▪ What it is
N-acetylcysteine (NAC) at 600mg three times daily for three consecutive days per week, an intermittent protocol based on an Italian cohort study showing reduced endometrioma growth and pain, framed honestly as observational evidence pending a randomized controlled trial.
▪ Why this is surprising
A cohort study found NAC reduced endometrioma diameter and prevented new cyst formation over 3 months, with effects the authors note compare favorably to oral contraceptives in terms of cyst size reduction. The evidence is observational (not a randomized trial), hence the emerging confidence rating, but the magnitude of the finding and the consistent mechanistic rationale (peritoneal oxidative stress in endometriosis) make it the most striking non-prescription supplement signal in this category. The dose and schedule are specific: 600mg 3x/day for 3 consecutive days per week.
▪ How it works
Cutting the oxidative stress that feeds lesion growth.
NAC is a precursor to glutathione, which neutralizes reactive oxygen species. Oxidative stress in the peritoneal cavity is a well-established feature of endometriosis, where it contributes to lesion growth, adhesion formation, and peritoneal inflammation. NAC also has anti-inflammatory effects through NF-κB pathway inhibition and may reduce prostaglandin production. In the endometrioma specifically, reducing oxidative stress in the cyst environment may slow the growth and proliferation of the cystic tissue.
▪ The research
What the evidence says
An observational cohort study of 92 Italian women with ultrasound-confirmed ovarian endometriomas scheduled for laparoscopy found that those who chose to take NAC (600mg 3x/day for 3 consecutive days per week for 3 months) showed a mean cyst diameter reduction of 1.5mm versus a significant increase of 6.6mm in untreated controls (P=0.001). A 2023 prospective cohort study by the same group found NAC reduced endometriosis-related pain, endometrioma size, and serum CA-125. Neither study was a randomized controlled trial.
Porpora MG et al. Evid Based Complement Alternat Med. 2013;2013:240702. PMID: 23737821. (Also: Anastasi E et al., 2023 prospective cohort, PMID: 36981595.)
started
completed
noticed a change
made it routine
▪ What to look for
A practical buying guide
NAC is widely available OTC and inexpensive. The dosing schedule in the study was 600mg 3x/day for 3 consecutive days per week, not continuous daily use, which is the specific protocol the evidence is built on. Standard 600mg NAC capsules match the study dose.
Coco is the AI health coach that runs experiments like this one with you
Know exactly what to do: Coco sets the protocol and checks in by call or message
See what's actually changing: Coco tracks your symptoms and synthesizes the trend
Get a real answer: Coco tells you whether the data supports continuing or stopping
▪ What to expect over time
The cohort study measured endometrioma changes at 3 months of the intermittent weekly protocol. Don't draw conclusions about effect before that timeframe.
Side effects
Generally well tolerated. Nausea, GI upset, and rotten-egg smell from sulfur compounds. May thin mucus (relevant if respiratory conditions co-exist).
Who should be cautious
Avoid concurrent use with nitroglycerin (which NAC potentiates). Theoretical concern with concurrent immunosuppressants. These studies were conducted in non-pregnant women; avoid in pregnancy without specific guidance. This is emerging evidence, not an established treatment, and shouldn't replace standard medical care for endometriosis. Always consult a care provider when adding or removing a supplement from your routine.
FAQ
Why isn't the confidence rated higher if the results looked so good?
Can I take this alongside my other endometriosis treatments?
Is Coco a replacement for my doctor?
Coco helps you turn health ideas like this into small, trackable experiments you can actually stick with.
The hard part isn't starting — it's knowing if it's working
Stay consistent: Coco checks in so you don't have to rely on motivation
See clearly: Coco reads your symptom data so you can trust what you're seeing
Get a real answer: Coco tells you whether it's working, even if it isn't
Educational only. This is not medical advice. Always talk with a qualified clinician before changing medications, supplements, or care plans.